Squamous cell cancers: a unified perspective on biology and genetics

GP Dotto, AK Rustgi - Cancer cell, 2016 - cell.com
Squamous cell carcinomas (SCCs) represent the most frequent human solid tumors and are
a major cause of cancer mortality. These highly heterogeneous tumors arise from closely …

[HTML][HTML] Pathways and therapeutic targets in melanoma

E Shtivelman, MA Davies, P Hwu, J Yang, M Lotem… - Oncotarget, 2014 - ncbi.nlm.nih.gov
This review aims to summarize the current knowledge of molecular pathways and their
clinical relevance in melanoma. Metastatic melanoma was a grim diagnosis, but in recent …

How the TP53 Family Proteins TP63 and TP73 Contribute to Tumorigenesis: Regulators and Effectors

E Candi, M Agostini, G Melino, F Bernassola - Human mutation, 2014 - Wiley Online Library
In mammals, the p53 family comprises two additional members, p63 and p73 (hereafter
referred to as TP 53, TP 63, and TP 73, respectively). The usage of two alternative promoters …

The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.

P Orzol, J Holcakova, M Nekulova… - Histology and …, 2014 - europepmc.org
p63 and p73, the two other members of the p53 family, were identified almost 15 years ago.
Here, we review their potential use for diagnosis, prognosis and prediction of response to …

p53 family in resistance to targeted therapy of melanoma

I Vlašić, A Horvat, A Tadijan, N Slade - International journal of molecular …, 2022 - mdpi.com
Metastatic melanoma is one of the most aggressive tumors, with frequent mutations affecting
components of the MAPK pathway, mainly protein kinase BRAF. Despite promising initial …

Diagnostic immunohistochemistry in cutaneous neoplasia: an update

LA Compton, GF Murphy, CG Lian - Dermatopathology, 2015 - karger.com
Immunohistochemistry (IHC) is an important adjunct in the diagnosis of neoplastic skin
diseases. In addition to the many established IHC markers currently in use, new markers …

Altered expression of shorter p53 family isoforms can impact melanoma aggressiveness

A Tadijan, F Precazzini, N Hanžić, M Radić, N Gavioli… - Cancers, 2021 - mdpi.com
Simple Summary TP53 is one of the most important tumor suppressor genes, which has
been found to be mutated in more than half of human cancers and is considered the …

IL-1β induces up-regulation of BIRC3, a gene involved in chemoresistance to doxorubicin in breast cancer cells

M Mendoza-Rodríguez, HA Romero… - Cancer letters, 2017 - Elsevier
Epithelial to mesenchymal transition (EMT) of tumor cells facilitates their progress to
metastasis. In the tumor microenvironment the inflammatory cytokine 1β (IL-1β) has been …

Dicer interacts with SIRT7 and regulates H3K18 deacetylation in response to DNA damaging agents

PY Zhang, G Li, ZJ Deng, LY Liu, L Chen… - Nucleic acids …, 2016 - academic.oup.com
Dicer participates in heterochromatin formation in fission yeast and plants. However,
whether it has a similar role in mammals remains controversial. Here we showed that the …

Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition

P Dietrich, S Kuphal, T Spruss, C Hellerbrand… - Oncogene, 2018 - nature.com
Malignant melanoma reveals rapidly increasing incidence and mortality rates worldwide. By
now, BRAF inhibition is the standard therapy for advanced melanoma in patients carrying …